• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型假性甲状旁腺功能减退症患者培养的成纤维细胞膜中鸟嘌呤核苷酸调节单位活性不足。完整细胞和破碎细胞合成3',5'-环磷酸腺苷受损的一个原因。

Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.

作者信息

Levine M A, Eil C, Downs R W, Spiegel A M

出版信息

J Clin Invest. 1983 Jul;72(1):316-24. doi: 10.1172/jci110971.

DOI:10.1172/jci110971
PMID:6308048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1129187/
Abstract

Deficient activity of the guanine nucleotide regulatory protein (G unit), an integral component of the membrane-bound adenylate cyclase complex, has been implicated as the biochemical lesion in many patients with pseudohypoparathyroidism (PHP) type I. In addition to renal resistance to parathyroid hormone in this disorder, there is decreased responsiveness of diverse tissues to hormones that act via 3',5'-cyclic AMP (cAMP). To assess whether a deficiency of G units could account for impaired adenylate cyclase activity, we studied cAMP production in intact cultured fibroblasts and fibroblast plasma membranes from five patients with PHP in response to several activators of adenylate cyclase. The number of G units in PHP fibroblast membranes, measured by cholera toxin-dependent [(32)P]ADP ribosylation of G-unit peptides, as well as the G-unit activity, determined by the ability of detergent extracts to reconstitute adenylate cyclase activity in G-unit-deficient S49 CYC(-) membranes, were found to be markedly reduced compared with control membranes (43 and 40%, respectively), The activation of fibroblast membrane adenylate cyclase by effectors that act directly through the G unit (guanosine triphosphate, guanosine 5'-0-[3-thiotriphosphate] [GTP-gamma-S], NaF) was significantly greater in control membranes than in membranes from patients with PHP. Moreover, we found that hormone (prostaglandin E(1)) stimulated adenylate cyclase activity was also greater in control membranes than in PHP membranes. Neither the apparent affinity of membrane adenylate cyclase for GTP-gamma-S (apparent K(m) =5 X 10(-8) M) nor the rate of enzyme activation by GTP-gamma-S was significantly different in fibroblast membranes from control subjects and patients with PHP. In contrast to the notable differences in hormone and G-unit-activated adenylate cyclase shown in fibroblast membranes from PHP patients and control subjects, the intrinsic catalytic activity of membranes, as determined by forskolin-stimulated adenylate cyclase, was not significantly different in the two groups. Intact fibroblasts derived from patients with PHP accumulated significantly (P 0.001) less cAMP (46+/-21 pmol cAMP/mcg DNA, n = 5) than cells from normal individuals (170+/-51 pmol cAMP/mcg DNA, n = 11) when stimulated with PGE(1). PGE(1)-stimulated accumulation of cAMP by intact fibroblast monolayers correlated closely with PGE(1) plus GTP-activated membrane adenylate cyclase activity in both patients and controls (r = 0.97, P < 0.001). Our data show that, in patients with PHP, (a) fibroblast membranes show a decreased complement of G units, (b) membrane catalytic activity is normal, but adenylate cyclase activity is reduced when stimulated by hormone or by effectors which activate the G unit, (c) the ability of cells to accumulate cAMP in response to hormone stimulation is reduced, and (d) reduced membrane adenylate cyclase activity correlates well with impaired cellular cAMP synthesis. These results, taken together, indicate that a deficiency of G-unit activity can impair synthesis of cAMP by both intact and broken cells, and may explain the resistance of multiple tissues to hormones that act via cAMP observed in PHP.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/1129187/7d4a7bac2c1b/jcinvest00767-0335-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/1129187/7d4a7bac2c1b/jcinvest00767-0335-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/1129187/7d4a7bac2c1b/jcinvest00767-0335-a.jpg
摘要

鸟嘌呤核苷酸调节蛋白(G单位)是膜结合腺苷酸环化酶复合物的一个组成部分,其活性不足被认为是许多I型假性甲状旁腺功能减退症(PHP)患者的生化损伤。除了该疾病中肾脏对甲状旁腺激素的抵抗外,多种组织对通过3',5'-环磷酸腺苷(cAMP)起作用的激素的反应性也降低。为了评估G单位的缺乏是否可以解释腺苷酸环化酶活性受损,我们研究了来自5例PHP患者的完整培养成纤维细胞和成纤维细胞质膜中cAMP的产生情况,以响应几种腺苷酸环化酶激活剂。通过霍乱毒素依赖性[(32)P]ADP核糖基化G单位肽来测量PHP成纤维细胞膜中G单位的数量,以及通过去污剂提取物在G单位缺陷的S49 CYC(-)膜中重建腺苷酸环化酶活性的能力来确定G单位活性,发现与对照膜相比显著降低(分别为43%和40%)。通过直接作用于G单位的效应物(鸟苷三磷酸、鸟苷5'-O-[3-硫代三磷酸][GTP-γ-S]、氟化钠)激活成纤维细胞膜腺苷酸环化酶在对照膜中比在PHP患者的膜中显著更强。此外,我们发现激素(前列腺素E1)刺激的腺苷酸环化酶活性在对照膜中也比在PHP膜中更高。对照受试者和成纤维细胞患者的成纤维细胞膜中,膜腺苷酸环化酶对GTP-γ-S的表观亲和力(表观K(m)=5×10(-8)M)以及GTP-γ-S对酶的激活速率均无显著差异。与PHP患者和对照受试者的成纤维细胞膜中激素和G单位激活的腺苷酸环化酶的显著差异相反,由福斯可林刺激的腺苷酸环化酶测定的膜内在催化活性在两组中无显著差异。当用PGE1刺激时,来自PHP患者的完整成纤维细胞积累的cAMP(46±21 pmol cAMP/μg DNA,n = 5)比正常个体的细胞(170±51 pmol cAMP/μg DNA,n = 11)显著少(P<0.001)。PGE1刺激完整成纤维细胞单层积累cAMP在患者和对照中均与PGE1加GTP激活的膜腺苷酸环化酶活性密切相关(r = 0.97,P<0.001)。我们的数据表明,在PHP患者中,(a)成纤维细胞膜显示G单位的补充减少,(b)膜催化活性正常,但当受到激素或激活G单位的效应物刺激时腺苷酸环化酶活性降低,(c)细胞响应激素刺激积累cAMP的能力降低,并且(d)降低的膜腺苷酸环化酶活性与受损的细胞cAMP合成密切相关。这些结果综合起来表明,G单位活性的缺乏可损害完整细胞和破碎细胞中cAMP的合成,并可能解释在PHP中观察到的多种组织对通过cAMP起作用的激素的抵抗。

相似文献

1
Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.I型假性甲状旁腺功能减退症患者培养的成纤维细胞膜中鸟嘌呤核苷酸调节单位活性不足。完整细胞和破碎细胞合成3',5'-环磷酸腺苷受损的一个原因。
J Clin Invest. 1983 Jul;72(1):316-24. doi: 10.1172/jci110971.
2
Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.I型假性甲状旁腺功能减退症中的成纤维细胞缺陷:受体 - 环化酶偶联蛋白活性降低
J Clin Endocrinol Metab. 1981 Sep;53(3):636-40. doi: 10.1210/jcem-53-3-636.
3
New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase.
Am J Physiol. 1989 Aug;257(2 Pt 1):E277-83. doi: 10.1152/ajpendo.1989.257.2.E277.
4
Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.假性甲状旁腺功能减退患者的血小板:不同受体-环化酶偶联蛋白介导腺苷酸环化酶刺激和抑制的证据。
Proc Natl Acad Sci U S A. 1982 Jul;79(13):4193-7. doi: 10.1073/pnas.79.13.4193.
5
The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma cyc- and wild type membranes.腺苷酸环化酶的抑制性鸟嘌呤核苷酸结合调节成分。S49淋巴瘤cyc-和野生型膜中的亚基解离及腺苷酸环化酶的抑制
J Biol Chem. 1984 Mar 25;259(6):3586-95.
6
Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex.前列腺素E诱导的肝腺苷酸环化酶异源脱敏。对鸟苷酸调节复合物的影响。
J Biol Chem. 1983 Jul 25;258(14):8692-7.
7
Activation of adenylate cyclase in bovine corpus-luteum membranes by human choriogonadotropin, guanine nucleotides and NaF.人绒毛膜促性腺激素、鸟嘌呤核苷酸和氟化钠对牛黄体膜中腺苷酸环化酶的激活作用。
Biochem J. 1981 Sep 15;198(3):631-8. doi: 10.1042/bj1980631.
8
ADP-ribosylation by cholera toxin of membranes derived from brain modifies the interaction of adenylate cyclase with guanine nucleotides and NaF.霍乱毒素对源自大脑的膜进行的ADP核糖基化修饰了腺苷酸环化酶与鸟嘌呤核苷酸及氟化钠的相互作用。
J Neurochem. 1988 Jun;50(6):1791-7. doi: 10.1111/j.1471-4159.1988.tb02480.x.
9
Increased membrane-associated nucleoside diphosphate kinase activity as a possible basis for enhanced guanine nucleotide-dependent adenylate cyclase activity induced by picolinic acid treatment of simian virus 40-transformed normal rat kidney cells.膜相关核苷二磷酸激酶活性增加,可能是吡啶甲酸处理猿猴病毒40转化的正常大鼠肾细胞诱导鸟嘌呤核苷酸依赖性腺苷酸环化酶活性增强的基础。
J Biol Chem. 1983 Oct 25;258(20):12609-17.
10
Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism.
J Clin Invest. 1983 Feb;71(2):231-5. doi: 10.1172/jci110763.

引用本文的文献

1
Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment.假性甲状旁腺功能减退症患者伴新型 GNAS 框移突变致静脉血栓形成,乙酰唑胺治疗后血管钙化完全消退。
Horm Res Paediatr. 2024;97(4):404-415. doi: 10.1159/000534456. Epub 2023 Oct 31.
2
Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.因GNAS基因失活导致的奥尔布赖特遗传性骨营养不良中的异常骨调节:机制及转化意义
Curr Osteoporos Rep. 2022 Feb;20(1):78-89. doi: 10.1007/s11914-022-00719-w. Epub 2022 Feb 28.
3

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Further studies on pseudo-hypoparathyroidism: report of four new cases.假性甲状旁腺功能减退症的进一步研究:四例新病例报告
Acta Endocrinol (Copenh). 1950;5(3):199-225. doi: 10.1530/acta.0.0050199.
3
Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism.
J Clin Invest. 1983 Feb;71(2):231-5. doi: 10.1172/jci110763.
Parental Origin of Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.
失活的亲本来源对奥尔布赖特遗传性骨营养不良小鼠模型中的骨重塑有不同影响。
JBMR Plus. 2021 Nov 16;6(1):e10570. doi: 10.1002/jbm4.10570. eCollection 2022 Jan.
4
Short Stature is Progressive in Patients with Heterozygous NPR2 Mutations.杂合 NPR2 突变患者的身材矮小呈进行性发展。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3190-202. doi: 10.1210/clinem/dgaa491.
5
Management of pseudohypoparathyroidism.假性甲状旁腺功能减退症的管理。
Curr Opin Pediatr. 2019 Aug;31(4):537-549. doi: 10.1097/MOP.0000000000000783.
6
Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.奥尔布赖特遗传性骨营养不良中的骨化:基因型、遗传方式、性别、年龄、激素状态和 BMI 的作用。
J Clin Endocrinol Metab. 2018 Jan 1;103(1):158-168. doi: 10.1210/jc.2017-00860.
7
GNAS Spectrum of Disorders.GNAS相关疾病谱
Curr Osteoporos Rep. 2015 Jun;13(3):146-58. doi: 10.1007/s11914-015-0268-x.
8
The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene.GNAS 复合物基因座和与该印记基因内功能丧失突变或表观遗传突变相关的人类疾病。
Horm Res Paediatr. 2013;80(4):229-41. doi: 10.1159/000355384. Epub 2013 Oct 3.
9
Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy.阿卜特遗传性骨营养不良症小鼠模型中的异位骨化。
PLoS One. 2011;6(6):e21755. doi: 10.1371/journal.pone.0021755. Epub 2011 Jun 29.
10
A new mutation in the growth hormone-releasing hormone receptor gene in two Israeli Arab families.两个以色列阿拉伯家庭中生长激素释放激素受体基因的新突变。
J Endocrinol Invest. 2006 Feb;29(2):122-30. doi: 10.1007/BF03344084.
4
Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.假性甲状旁腺功能减退患者对多种激素的抵抗。与鸟嘌呤核苷酸调节蛋白活性不足相关。
Am J Med. 1983 Apr;74(4):545-56. doi: 10.1016/0002-9343(83)91008-2.
5
Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.假性甲状旁腺功能减退患者的血小板:不同受体-环化酶偶联蛋白介导腺苷酸环化酶刺激和抑制的证据。
Proc Natl Acad Sci U S A. 1982 Jul;79(13):4193-7. doi: 10.1073/pnas.79.13.4193.
6
Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism.激素受体 - 腺苷酸环化酶偶联蛋白缺乏:假性甲状旁腺功能减退症激素抵抗的基础。
Am J Physiol. 1982 Jul;243(1):E37-42. doi: 10.1152/ajpendo.1982.243.1.E37.
7
Down syndrome fibroblasts are hyperresponsive to beta-adrenergic stimulation.唐氏综合征成纤维细胞对β-肾上腺素能刺激反应过度。
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7670-3. doi: 10.1073/pnas.78.12.7670.
8
Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.I型假性甲状旁腺功能减退症中的成纤维细胞缺陷:受体 - 环化酶偶联蛋白活性降低
J Clin Endocrinol Metab. 1981 Sep;53(3):636-40. doi: 10.1210/jcem-53-3-636.
9
Deficient activity of receptor-cyclase coupling protein in platelets of patients with pseudohypoparathyroidism.
J Clin Endocrinol Metab. 1980 Nov;51(5):1202-4. doi: 10.1210/jcem-51-5-1202.
10
Hormone-stimulated cyclic AMP production by skin fibroblasts cultured from healthy persons and patients with cystic fibrosis.健康人和囊性纤维化患者皮肤成纤维细胞经激素刺激后的环磷酸腺苷生成情况。
Pediatr Res. 1980 Jul;14(7):863-8. doi: 10.1203/00006450-198007000-00004.